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Abstract
β-Catenin is important in liver homeostasis as a part of Wnt signaling and adherens junctions (AJs), while its aber-
rant activation is observed in hepatocellular carcinoma (HCC). We have reported hepatocyte-specific β-catenin
knockout (KO) mice to lack adhesive defects as γ-catenin compensated at AJ. Because γ-catenin is a desmosomal
protein, we asked if its increase in KO might deregulate desmosomes. No changes in desmosomal proteins or
ultrastructure other than increased plakophilin-3 were observed. To further elucidate the role and regulation of
γ-catenin, we contemplate an in vitromodel and show γ-catenin increase in HCC cells upon β-catenin knockdown
(KD). Here, γ-catenin is unable to rescue β-catenin/T cell factor (TCF) reporter activity; however, it sufficiently com-
pensates at AJs as assessed by scratch wound assay, centrifugal assay for cell adhesion (CAFCA), and hanging
drop assays. γ-Catenin increase is observed only after β-catenin protein decrease and not after blockade of its
transactivation. γ-Catenin increase is associated with enhanced serine/threonine phosphorylation and abrogated by
protein kinase A (PKA) inhibition. In fact, several PKA-binding sites were detected in γ-catenin by in silico analysis.
Intriguingly γ-catenin KD led to increasedβ-catenin levels and transactivation. Thus, γ-catenin compensates forβ-catenin
loss at AJ without affecting desmosomes but is unable to fulfill functions in Wnt signaling. γ-Catenin stabilization after
β-catenin loss is brought about by PKA. Catenin-sensingmechanismmay depend on absolute β-catenin levels and not
its activity. Anti–β-catenin therapies for HCC affecting total β-catenin may target aberrant Wnt signaling without neg-
atively impacting intercellular adhesion, provided mechanisms leading to γ-catenin stabilization are spared.
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Introduction
Hepatocellular carcinoma (HCC) is the fifth most common cancer
worldwide, and the severity of the disease has resulted in it becoming
the third leading cause of cancer-related deaths worldwide [1,2].
Only about one-third of HCCs are curable by surgical resection, and
the current treatments for the majority of HCC cases involve non-
targeted palliative care, such as systemic chemotherapies [3]. Therefore,
understanding and treating this disease at a cellular and molecular level
becomes imperative to relieve this major health burden. Pathologically,
an abnormal distribution of the armadillo family protein β-catenin has
been described in up to 90% of HCC cases [4–6]. Of these, β-catenin
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gene (CTNNB1) mutations have been reported in 30% [7]. On the
basis of the many roles of β-catenin in HCC biology, it has been dis-
cussed as a potential therapeutic target. Our laboratory and others have
recently proposed a number of unique anti–β-catenin therapies for the
treatment of HCC [8–11].
β-Catenin is an essential component of Wnt signaling pathway
[12]. Wnt/β-catenin is important in liver homeostasis and regulates
zonation, development, metabolism, proliferation, and regeneration
[13]. Additionally, β-catenin is also a key component of cell-cell adhe-
sions at the adherens junctions (AJs), where it links the transmembrane
protein E-cadherin to the actin cytoskeleton. Despite β-catenin’s critical
role in the liver, we previously published that a hepatocyte-specific β-
catenin knockout (KO) mouse was viable and had no overt adhesive
defect [14]. We also showed that with loss of hepatic β-catenin there
is an increase of γ-catenin (plakoglobin) over the wild type (WT), spe-
cifically at the AJ. γ-Catenin is a major protein in cell-cell adhesion at
the desmosomes, where it also links transmembrane cadherins (desmo-
gleins and desmocollins) to intermediate filaments of the actin cytoskel-
eton. γ-Catenin is found in the armadillo family of proteins along with
β-catenin, shares nearly an 80% homology to β-catenin, and has a nearly
identical interaction with E-cadherin [15]. There have also been reports
that γ-catenin has potential nuclear functions through the Wnt signal-
ing pathway in β-catenin–null cell lines [16,17].
Cell-cell junctions are essential to proper hepatocyte functionality.
Hepatocyte junctions regulate the flow of molecules between hepato-
cytes, help maintain cellular polarity, and create barriers within the
liver. Compromised barriers occur in liver pathologies, such as chole-
stasis [18], biliary cirrhosis [19], and HCC. Studies have shown that
the levels of AJ and desmosomal protein expression correlate with the
differentiation status of clinical HCC cases. In poorly differentiated
HCC cases, more than 50% of tumor cells and nearly 100% of cancer
cells no longer expresses AJ and desmosomal components [20]. Addi-
tionally, HCC patients with underexpression of γ-catenin have a poor
survival [21]. Therefore, dysregulated junctions are observed in HCC.
In the present study, we demonstrate that the in vivo compensa-
tion of γ-catenin in β-catenin KO mice does not come at the expense
of desmosomes. We show in an in vitro model that γ-catenin allevi-
ates β-catenin loss at AJ to maintain cell-cell adhesion but is unable
to fulfill its role in the canonical Wnt signaling. Lastly, we identify
the mechanism of γ-catenin stabilization to be serine/threonine phos-
phorylation induced by protein kinase A (PKA). Thus, we show that
β-catenin–lowering agents may be a viable option for HCC treat-
ment, provided γ-catenin stabilization mechanisms are spared.
Materials and Methods
Animals
All animal studies were approved by the University of Pittsburgh
Institutional Animal Care and Use Committee office. Homozygous
floxed β-catenin mice (C57BL/6 strain) and albumin-cre transgenic
mice were bred as previously described [14]. Mice with genotype
CTNNB1lox/lox; Alb-Cre+/− are referred to as KOs. Littermates with
floxed β-catenin genotypes were used as WT controls. Livers from
age- and sex-matched 60- to 120-day-old KO and WT (n < 4) were
used, unless otherwise noted.
Cell Lines and Treatments
Hep3B and HepG2 human HCC cell lines were obtained from
the American Type Culture Collection (Manassas, VA). Cells were
cultured in Eagle’s minimal essential medium (EMEM) supplemented
with 10% vol/vol FBS at 37°C in a humidified 5% carbon dioxide
atmosphere. For transient transfection, the cells were plated in six-well
plates and grown to 60% to 80% confluence, followed by serum star-
vation for 4 to 16 hours. For siRNA KD, the cells were transfected
using Lipofectamine 2000 (Life Technologies, Grand Island, NY)
and a total siRNA concentration of 75 nM and/or DNA concentration
of 500 ng inOpti-MEM IMedia (Life Technologies) for 24 to 72 hours
as per the manufacturer’s instructions. Human γ-catenin ( JUP), pre-
validated β-catenin (CTNNB1), and scrambled Negative Control 2
Silencer Select siRNAs were purchased from Ambion (Grand Island,
NY). Additionally, CTNNB1 (ISIS102708) or control antisense oligo-
nucleotides (ASOs; ISIS Pharmaceuticals Inc, Carlsbad, CA) were used
for transient transfections at a concentration of 50 nM for 24, 48, or
72 hours as previously published [22]. Small molecule inhibitor of
β-catenin nuclear activity, ICG-001, was used for cell treatments at
10 mM as previously published [8]. All experiments were performed
in triplicate.
Hep3B cells were also treated with the phosphatase inhibitor
okadaic acid (OA) (Santa Cruz Biotechnology, Santa Cruz, CA) at 25
and 10 nM, as previously published, for 3 hours [23]. After transfect-
ing Hep3B cells for 21 or 45 hours with β-catenin or control siRNA
against β-catenin, serine/threonine kinase inhibitors, purchased from
Calbiochem (Billerica, MA), were administered for 3 hours at the fol-
lowing concentrations: H-89 at 20 μM [24], protein kinase G (PKG)
inhibitor (RKRARKE) at 200 μM [25], bisindolylmaleimide I at 1 μM
[26], KN-93 at 5 μM [27], ML-7 at 30 μM [28], staurosporine at 1 μM
[29]. Cells were washed and used for whole-cell lysate (WCL) and
Western blot (WB).
β-Catenin/TCF Transcription Reporter Assay
Cells were transiently transfected with the reporter construct
TOPf lash (Upstate, Lake Placid, NY), which has three copies of
T cell factor (TCF)/LEF sites upstream of a thymidine kinase pro-
moter and the firefly luciferase gene. Cells were co-transfected with
Renilla luciferase to control for transfection efficiency. This reporter
system has been successfully used to detect both β- and γ-catenin–
dependent Wnt signaling [16,30]. Luciferase assays were performed
using Dual-Luciferase Reporter Assay System (Promega, Madison,
WI). Average relative light units from triplicate experiments were
compared for statistical significance by Student’s t test.
Protein Extraction
WCLs were obtained using radioimmunoprecipitation assay buffer
containing fresh protease and phosphatase inhibitor cocktails (Sigma,
St Louis, MO) as described previously [14]. Cytoskeleton-associated
proteins were also extracted as described previously [31] to obtain
Triton X-100–insoluble (I) or cytoskeletal-associated lysates (CALs).
Nuclear lysates were extracted using NE-PERNuclear and Cytoplasmic
Extraction Kit as per the manufacturer’s instructions (Pierce, Rockford,
IL). Protein assays were performed using BCA protein assays (Pierce).
Western Blot
A total of 10 to 20 μg of protein was resolved on Tris-HCl precast
gels (Bio-Rad Laboratories, Hercules, CA) by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis analysis using theMini-PROTEAN 3
Electrophoresis Module Assembly (Bio-Rad Laboratories). The resolved
proteins were transferred to polyvinylidene difluoride membranes and
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the signal was detected by SuperSignal West Pico Chemiluminescent
Substrate (Pierce). HRP-conjugated secondary antibodies were pur-
chased from Millipore (Billerica, MA). Whenever necessary, WBs
were quantified using ImageJ software (National Institutes of Health,
Bethesda, MD). A complete list of primary antibodies and dilutions is
provided in Table W1.
Immunoprecipitation
Co-precipitation studies were performed with 200 to 500 μg of WCL
or CAL as described elsewhere [31]. Antibodies used for immuno-
precipitation (IP) were rabbit anti–γ-catenin (Cell Signaling Technology,
Danvers, MA), rabbit anti–E-cadherin (Santa Cruz Biotechnology), or
goat β-catenin–conjugatedA/Gagarose beads (SantaCruzBiotechnology).
Immunofluorescence
Staining was performed using goat anti–γ-catenin (sc-30997) or
rabbit anti–β-catenin (sc-7199; Santa Cruz Biotechnology), primary
antibodies, and Alexa 488–conjugated donkey anti-goat and Alexa
555–conjugated donkey anti-rabbit (Life Technologies) secondary
antibodies, as described elsewhere [32]. Sections were counterstained
with 4’,6-diamidino-2-phenylindole (DAPI) and imaged with Olym-
pus 1000 Confocal Microscope with Fluoview 1.7A software (Center
Valley, PA).
Transmission Electron Microscopy
Liver tissue was fixed with 2.5% glutaraldehyde in phosphate-
buffered saline (PBS) by perfusion through the inferior vena cava.
Transmission electron microscopy (TEM) was performed as described
previously [33]. Briefly, after fixation and sectioning, grids were hand
stained with 2% uranyl acetate in 50% methanol for 10 minutes and
1% lead citrate for 7 minutes. Digital TEM images were taken with
JEOL JEM-1011 Transmission Electron Microscope (Peabody, MA)
at 80.0 kV. Quantitative analysis of junctions was done with Meta-
Morph Software (Molecular Devices, Sunnyvale, CA).
Microarray Analysis
Livers from three KO and WT were used for Affymetrix (Santa
Clara, CA) gene array analysis as previously published [14]. The signals
from KO and WT livers were compared and presented as fold change.
Real-Time Polymerase Chain Reaction
RNA was extracted from treated Hep3B cells using TRIzol (Life
Technologies) and was DNAse-treated using the TURBO DNAse
Kit (Ambion) as per the manufacturer’s instructions. The RNA
was used for real-time polymerase chain reaction (PCR) analysis as
described elsewhere [34]. Comparative delta-delta Ct (DDCT)
method was used for analysis of the data, and calculations were made
without the StepOne software (Applied Biosystems, Grand Island,
NY). Real-time PCR primer sequences are available in Table W2.
Proliferation Assay ([ 3H]Thymidine Incorporation)
Proliferation analyses were performed as previously described
[35]. Briefly, 24 hours after siRNA transfection in Hep3B cells,
[3H]thymidine (2.5 mCi/ml) was added to culture media. The cells
were cultured for [3H]thymidine incorporation for an additional 24 to
48 hours. The cells were then washed with 5% ice-cold trichloroacetic
acid (TCA) and lysed with 0.33 M NaOH. Aliquots diluted in scintil-
lation fluid were used to determine [3H]thymidine incorporation on a
Beckman Scintillation counter (Brea, CA). Average counts per minute
from triplicate experiments were compared for statistical significance by
Student’s t test.
Scratch Wound Assay
Wound-healing assays were performed as previously described
[36]. Briefly, cells were grown as a confluent monolayer and trans-
fected for 24 hours, and a wound was made using a p10 pipette tip.
During the assay, cells were cultured in 0.5% EMEM to decrease the
influence of cell proliferation. Cells were imaged periodically for 24
additional hours until the wound fronts began to merge. The wounds
were imaged at four different locations for each time point using
phase-contrast filters at 5× magnification on an Axioskop 40 (Zeiss,
Thornwood, NY) inverted brightfield microscope, and the cell-free
area of the scratches was quantified at each time point using ImageJ
software (National Institutes of Health). Percentage of wound closure
from triplicate experiments was compared for statistical significance
by Student’s t test.
Cell-Cell Adhesion Assays
CAFCA was performed as previously described [36]. Briefly, trans-
fected cells were prelabeled with CellTracker Green CMFDA (Life
Technologies) for 15 minutes at 37°C, non-enzymatically dissociated
from the monolayers using a 1:200 dilution of 500 mM EGTA and
500 mM EDTA in calcium and magnesium-free Hank’s balanced
salt solution, and resuspended in 10% EMEM to be replated on
unlabeled confluent monolayer of non-transfected cells cultured on
collagen-coated plates. After 30 minutes, the wells were washed once
with PBS to remove cells that did not attach, and fluorescence inten-
sity of labeled cells was quantified using a plate fluorometer at 495/
515 nm. The inverted plate was centrifuged at 375g in airtight cham-
ber filled with warm culture media for 10 minutes. Cells were washed
and fluorescence intensity of the remaining labeled cells was mea-
sured. A value of 100% attachment was assigned to the fluorescent
measurement recorded for each well before centrifuging the plate,
and experimental data were expressed as a percentage of cells lost
versus the initial 495/515 nm reading. Percentage of cells lost from
triplicate experiments was compared for statistical significance by
Student’s t test.
Hanging drop assay was performed as described previously [37].
Briefly, treated cells were removed from their monolayer using trypsin
and counted. The cells were resuspended in 2% EMEM at a concen-
tration of 2.5 × 105 cells/ml, and 20 μl of drops containing 5000 cells/
drop was pipetted onto the inner surface of a 10-cm2 dish lid. The
bottom of the petri dish was filled with 8 ml of PBS to prevent evap-
oration of the drops. The lid was placed back on the dish so that the
drops of cells were hanging from the lid, and the cells were incubated
for 20 hours at 37°C in a humidified 5% carbon dioxide atmosphere.
Some drops were pipetted up and down 20 times to assess dissociation
of cell colonies as a measurement of cadherin-mediated cell adhesion
activity. Coverslips were placed over the drops, and images were taken
using phase-contrast filters at 5× magnification on an Axioskop 40
(Zeiss) inverted brightfield microscope. Experiments were performed
in triplicate (n > 5).
Statistics
Student’s t test was performed using Microsoft Excel 2010 (Micro-
soft, Redmond, WA) to assess statistical significance for a minimum
of three different data points per experiment. Unless otherwise noted,
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significance was measured relative to control or siNegative treatments.
A P value of less than .01 was considered to be significant. Bar graphs
were made for each data set, and representative data are presented
with SDs of the mean indicated with error bars.
Results
β- and γ-Catenins Are Mutually Exclusive at
Hepatocyte Membranes
It has been recently reported that the albumin-Cre/Lox system of
knocking out genes in hepatocytes may sometimes be “leaky” especially
after about 6 months of age, causing some repopulation of KO livers
with β-catenin–positive hepatocytes [38,39].We used this anomaly as a
proof of concept. We performed immunofluorescence (IF) staining on
liver sections of an 8-month-old KO mice (on regular chow) to assess
the localization of β- and γ-catenins at the membrane of hepatocytes.
We previously reported that KO livers had an increase in γ-catenin co-
localization with E-cadherin at the AJ [31]. Here, we see that β-catenin
(red) and γ-catenin (green) appear to be mutually exclusive at the
hepatocyte membranes, with no co-localization (Figure 1A). Analysis
of the γ-catenin localization in the β-catenin–positive nodule shows a
desmosomal-like staining pattern, while γ-catenin localization in the
remainder of the KO liver section has an AJ-like staining pattern
(Figure 1A, inset, green channel).
The Increase of γ-Catenin with β-Catenin Loss Is Not at the
Expense of the Hepatic Desmosomes
γ-Catenin is able to compensate for β-catenin loss at the AJ by
binding to E-cadherin [31,37,40–45]. This increase in γ-catenin is
not transcriptional and may be a result of posttranslational stabiliza-
tion [31,41,46]. However, γ-catenin is primarily a desmosomal pro-
tein, so is this compensation at the cost of desmosomal integrity?
Initially, we used TEM to compare desmosome ultrastructure in
KO and WT livers. We see recognizable desmosomes in both KO
and WT (Figure 1B). Further analysis revealed no significant differ-
ence in intercellular distances at the point of desmosomal adhesions,
with mean distances of 27.4 nm in the KOs and 25.1 nm in the
WTs (P > .10).
Next, to investigate gene expression changes in desmosomal com-
ponents, we analyzed microarray data from KO and WT livers [14].
KO livers showed altered expression of desmocollin-2 (Dsc-2; +2.2-fold),
Dsc-3 (+3.8-fold), and plakophilin-3 (Pkp3, −3.7-fold; Table 1). Inter-
estingly,Dsc-3 has never been shown to be present in the desmosomes of
the livers, but we see a robust increase in mRNA expression in the KO
livers [20].
Since changes in mRNA levels do not always correspond to overall
protein levels, especially with catenins and cadherins [31], we wanted
to further analyze the protein expression of liver-specific desmosomal
proteins [47]. We analyzed soluble (S) and insoluble (I) CALs of
β-catenin KO and WT livers for desmosomal protein expression by
WBs (Figure 2A). β-Catenin KO livers show more soluble and insolu-
ble γ-catenin thanWTs byWBs (Figure 2B). We evaluated the levels of
desmoplakin I and II (DPI/II), desmoglein-1 (Dsg1), Dsg2, Dsg3,
Dsg4, Dsc-2, Pkp2, and Pkp3 (Figure 2A). There was no change in
overall protein levels, despite changes in some mRNA levels (Table 1);
interestingly, the protein Pkp3 is upregulated in S and I fractions
(Figure 2A), despite a −3.7-fold decrease inmRNA expression (Table 2).
Next, we assessed if there was a change in the desmosomal protein
association with γ-catenin. By IP, we show lack of any change in
DPI/II, Dsg1, Dsg2 (data not shown), and Dsg4 association with
γ-catenin between KO and WT livers in I fraction (Figure 2C )
and S fraction lysates (data not shown). In summary, the lack of ultra-
structural changes along with minimal changes in various desmosomal
proteins and lack of changes in γ-catenin’s interactions with various
desmosomal proteins supports the notion that changes γ-catenin in-
crease due to β-catenin loss is not at the expense of desmosomes.
No Qualitative Changes in Pkp3 with β-Catenin Loss
Next, we wanted to address if the species of Pkp3 that increased
with β-catenin loss had different binding partners, which affects its
trafficking in the cytoplasm. It was recently published that a complex
of γ-catenin, E-cadherin, and Pkp3 is required to initiate desmosome
formation [48]. Since both γ-catenin and Pkp3 are known binding
Figure 1. Assessment of AJs and desmosomes in β-catenin KO
and WT livers. (A) Membranous γ-catenin (green) and β-catenin
(red) are mutually exclusive at the cell membranes/AJ in β-catenin
of hepatocytes in β-catenin KO livers that become repopulated
with β-catenin–positive hepatocytes at elderly ages as shown by rep-
resentative double IF images of fixed liver sections. Boxes show the
staining pattern of γ-catenin (green channel) in β-catenin–positive
and β-catenin–negative sections of the KO liver. (B) TEM of β-catenin
KO andWT livers shows the presence of desmosomes (arrows). The
intercellular distance between hepatocytes connected by desmo-
somes is not significantly different (mean distances: KO = 27.4 nm,
WT = 25.1 nm; P > .10).
Table 1. Changes in Desmosomal mRNA Expression in β-Catenin KO in Microarray.




*Not normally in the liver [20].
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partners, and both were increased with β-catenin loss, we investigated if
these proteins associated more readily in the KO livers, possibly con-
tributing to their mutual stabilization. IP studies show that Pkp3 bind-
ing to both E-cadherin and γ-catenin was observed in the S and I (not
shown) CAL fractions, but there was no change in Pkp3 association
with β-catenin loss (Figure 2D). To further investigate the possible rea-
son for the increase in Pkp3 levels with β-catenin loss, we wanted to see if
the increase Pkp3 levels lead to increased nuclear Pkp3, since it has been
shown that Pkp3 has the potential to have nuclear functions [49]. Here,
we show that there is nuclear Pkp3 in theKO andWT livers, but there is
no difference with β-catenin loss (Figure 2E). Therefore, the changes in
Pkp3 levels with β-catenin loss cannot be explained by changes in cyto-
plasmic binding partners or with nuclear localization.
β-Catenin Knockdown in Hep3B Human Hepatoma Cells
Induces γ-Cateninto Replicate β-Catenin KO In Vivo
We next investigate if changes in γ-catenin due to chronic β-catenin
loss in vivo in hepatocytes can also occur acutely in vitro. siRNA-mediated
acute knockdown (KD) of β-catenin increases γ-catenin protein levels
in vitro in Hep3B, a humanHCC cell line (Figure 3A). As in the in vivo
model, siRNA KD of β-catenin induced E-cadherin–γ-catenin co-
precipitation in the Hep3B cells compared to the scrambled siRNA-
transfected cells (Figure 3B). Reciprocally, γ-catenin co-precipitates to
a greater extent with E-cadherin upon β-catenin KD in Hep3B cells
(Figure 3B, lower panel). Hence, the in vitro model using Hep3B cells
accurately replicates key observations seen in hepatocyte-specific KOmice.
To verify that the observed increase in γ-catenin in Hep3B cells after
siRNA-mediated β-catenin KD is not cell-specific or reagent-specific,
we next employed ASO to KD β-catenin in not only Hep3B but also
in HepG2 cells, which carry a monoallelic deletion of exon-3 in
CTNNB1 gene. ASO against β-catenin decreased its protein levels
and concomitantly increased the levels of γ-catenin (Figure 3C). These
data demonstrate that an increase in γ-catenin occurs with β-catenin
decrease regardless of the method of KD, cell line used, or presence
of full-length or mutated β-catenin in a hepatoma cell.
KD of β-Catenin Levels but Not Decrease in Its Activity
Induces γ-Catenin Increase in Hepatoma Cells
We next asked if the increase in γ-catenin occurs secondary to de-
crease in β-catenin levels, its activity, or both. We used a small molecule
Figure 2. β-Catenin KO mouse livers show no changes in desmosomal proteins, except Pkp3. (A) β-Catenin KO livers have no apparent
changes in most desmosomal protein levels in Triton X-100–soluble (S) and Triton X-100–insoluble/cytoskeleton-associated lysates (I)
through WBs, despite mRNA changes (Table 1): DPI (250 kDa), DPII (210 kDa), Dsg1 (150 kDa), Dsg2 (59–150 kDa), Dsg3 (55–130 kDa),
Dsg4 (100–115 kDa), Dsc2 (110 kDa), and Pkp2 (100 kDa). However, Pkp3 (87 kDa) is slightly increased in KO livers in both soluble (S)
and insoluble (I) CAL fractions overWT age- and sex-matched liver lysates. (B) β-Catenin KO livers showmore soluble and insoluble γ-catenin
(83 kDa) than WTs by WBs. WB for actin (42 kDa) verifies comparable loading. (C) Representative IPs of γ-catenin in insoluble CAL fraction
show no apparent changes in desmosomal protein associations with γ-catenin in β-catenin KO and WT livers. (D) Pkp3 co-precipitates with
γ-catenin (upper panel) and E-cadherin (lower panel) equally in the soluble CAL fractions of KO and WT livers. (E) Nuclear lysates show that
Pkp3 protein levels are similar between KO and WT livers.
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inhibitor of β-catenin’s nuclear functions, ICG-001, that binds to the
co-activator CREB-binding protein, a known histone acetyltransferase,
thereby disrupting the CREB-binding protein–β-catenin interactions to
downregulate β-catenin/TCF4–dependent target gene expression [8].
Indeed, treatment of Hep3B cells with ICG-001 led to decrease in
β-catenin target cyclin D1 (Figure 3D) and TOPflash luciferase reporter
activity (data not shown).However, unlike siRNAor ASO, ICG-001 does
not decrease overall β-catenin protein expression (Figure 3D). Intriguingly,
ICG-001 treatment did not lead to any increase in γ-catenin in these cells,
and if at all, a modest decrease was evident in these cells (Figure 3D).
Thus, these data suggest that cells sense a decrease in total β-catenin
protein and not its activity to trigger an increase in γ-catenin protein.
γ-Catenin Stabilization after β-Catenin KD Occurs through
PKA and PKG-Mediated Serine/Threonine Phosphorylation
Next, we assess the mechanism responsible for γ-catenin increase
following β-catenin down-regulation in HCC cells. First, we sought
any change inmRNA expression of γ-catenin gene ( JUP) after β-catenin
KD in Hep3B cells. As observed in vivo, we did not observe any change
in JUP expression despite an increase in γ-catenin protein (Figure 4A).
Next, on the basis of in vivo observations that γ-catenin increase in
β-catenin KO livers was associated with increased serine and threonine
phosphorylation of γ-catenin, we asked whether such posttranslational
modification could, in fact, stabilize γ-catenin in vitro. We treated
Hep3B cells with OA, a well-known inhibitor of serine/threonine
phosphatases [50,51]. Treatment of Hep3B cells for 3 hours with
OA led to an increase in total γ-catenin protein levels further support-
ing the role of serine/threonine phosphorylation in its stabilization
(Figure 4B).
To address which specific serine/threonine kinases may be respon-
sible for γ-catenin stabilization in Hep3B cells after β-catenin KD,
we used six different inhibitors with specific activities. As described
in Materials and Methods section, around 45 hours after transfection
of Hep3B cells with β-catenin or control siRNA, the cells were treated
with the inhibitors: H-89 (inhibits PKA, CaM kinase II, PKC and
casein kinase I); PKG inhibitor (inhibits PKG and PKA); bisindolyl-
maleimide I (PKC inhibitor); KN-93 (CaM kinase II inhibitor only);
ML-7 (inhibits myosin light chain kinase) and staurosporine (broad
range). We compared the extent of increase of γ-catenin upon β-catenin
KD following treatment with these inhibitors as assessed by densito-
metric analysis. While γ-catenin continued to increase around nine-fold
after β-catenin KD inHep3B cells when treated with DMSO,ML-7, or
KN-93 and around six-fold with BIS and staurosporine, only 1.75-fold
increase was evident after treatment with H-89 (Figure 4C). No impact
on γ-catenin was evident with water or PKG inhibitor treatment.
To further substantiate the role of PKA in γ-catenin stabilization
after β-catenin KD, we next studied response to 3 hours of H-89 at
low (150 nM) and high (20 μM) concentration on γ-catenin expres-
sion at 21 and 45 hours after β-catenin or control siRNA transfec-
tion. Both doses are within the range of specifically inhibiting PKA
since concentration of only 30 μM or more impacts other serine/
threonine kinases such as CaM kinase II, myosin light chain kinase,
and casein kinase I [52]. At a 24-hour time point, there was a two- to
three-fold induction in γ-catenin after β-catenin KD that was de-
creased by H-89 treatment at 150 nM or 20 μM by around 20%
(Figure 4D). However, at 48 hours, there was a decrease in γ-catenin
by around 40% with 150 nM and by 50% with 20 μM of H-89
treatment for 3 hours (Figure 4D). Lastly, using bioinformatics ap-
proach, we queried human γ-catenin protein sequence for potential
PKA kinase substrate motifs using the Human Protein Reference
Database PhosphoMotif Finder [53]. This led to the identification
of 23 putative PKA phosphorylation sites in both the human and
mouse junctional plakoglobin proteins, supporting the possibility
of PKA phosphorylation of γ-catenin (Table 2).
siRNA-Mediated Double KD of β- and γ-Catenins
In Vitro in Hep3B Cells
To try and effectively tease out the individual roles of β- and
γ-catenins inHCC cells and to address biologic implications of γ-catenin
stabilization following β-catenin KD, we investigated the feasibility
of double KD (dKD) of β- and/or γ-catenin in addition to single KD
(sKD) in Hep3B cells. WB analysis of siRNA-treated Hep3B cells at
24, 48, and 72 hours shows that the KD of these proteins is visible
by 24 hours after transfection and persists to at least 72 hours after
transfection (Figure 5A). Importantly, the increase in γ-catenin with
β-catenin KD is apparent at all time points (Figure 5A). Addition-
ally, the Hep3B cells transfected with single or double siRNAs ap-
pear healthy and viable at all time points tested and lacked any
obvious changes in cell morphology (data not shown).
γ-Catenin KD in Hep3B Cells Leads to
Increase in β-Catenin Expression
To address if analogous to β-catenin sKD γ-catenin sKD would
alter β-catenin levels, we assessed the impact of γ-catenin KD in
Table 2. Putative PKA Phosphorylation Sites on Human and Mouse Junctional Plakoglobin.
Sequence Position Motif Location
1 KVT 12–14 [R/K]X[pS/pT] N terminus
2 SSK 38–40 [pS/pT]X[R/K] N terminus





4 TAR 79–81 [pS/pT]X[R/K] N terminus
5 SKK 170–172 [pS/pT]X[R/K] Arm domain
KKEAS 171–175 KXXX[pS/pT]
KEAS 172–175 KXX[pS/pT]
6 SRR 175–177 [pS/pT]X[R/K] Arm domain
7 TAR 201–203 [pS/pT]X[R/K] Arm domain
RCT 203–205 [R/K]X[pS/pT]
8 RMLS 233–236 RXXpS Arm domain
9 RNYS 320–323 RXXpS C terminus
10 KLLWT 326–330 KXXX[pS/pT] C terminus
11 TSR 331–333 [pS/pT]X[R/K] C terminus
12 KVLS 336–339 KXX[pS/pT] C terminus
13 SNK 343–345 [pS/pT]X[R/K] C terminus
14 KHLT 359–362 KXX[pS/pT] C terminus
KHLTS 359–363 KXXX[pS/pT]
15 SPR 365–367 [pS/pT]X[R/K] C terminus
16 TLR 375–377 [pS/pT]X[R/K] C terminus
RNLS 377–380 RXXpS
17 KNKT 424–427 KXX[pS/pT] C terminus
KTLVT 426–430 KXXX[pS/pT]
18 KDDIT 448–452 KXXX[pS/pT] C terminus
19 TSR 463–465 [pS/pT]X[R/K] C terminus
20 SVR 475–477 [pS/pT]X[R/K] C terminus
21 KAT 499–501 [R/K]X[pS/pT] C terminus






23 TYR 700–702 [pS/pT]X[R/K] C terminus
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Hep3B cells. Interestingly, we observe an increase in β-catenin protein,
especially at 24 and 48 hours of γ-catenin siRNA transfection
(Figure 5A). This is in agreement with the recent cardiomyocyte-
specific γ-catenin KO mice, which show an increase in β-catenin pro-
tein levels. However, the literature is mixed on the role of this β-catenin
pool [54,55]. One study shows that the increase in β-catenin with
γ-catenin loss is localized to the AJ [54], while another report suggests
this increase to be nuclear since it led to an increase in β-catenin target
gene expression [55]. Therefore, we looked at the AJ composition with
γ-catenin sKD to see if there are any changes in β-catenin–E-cadherin
association. We observe no apparent changes in their association in
γ-catenin sKD (Figure 5B), indicating that the increase in β-catenin
is most likely occurring in the nuclear/cytoplasmic and thus signaling
pool of β-catenin in HCC cells.
γ-Catenin Does Not Compensate for β-Catenin–Mediated
Wnt Signaling In Vitro, while γ-Catenin KD Increases
β-Catenin/TCF Reporter Activity in HCC Cells
Wehave reported previously a lack of nuclear γ-catenin in hepatocyte-
specific β-catenin KOmice even at time of β-catenin–dependent hepato-
cyte proliferation such as 72 hours after partial hepatectomy, indicating
that γ-catenin was not compensating for nuclear β-catenin signaling
in vivo [31]. To test it in vitro, we used a TOPflash luciferase reporter to
assess TCF-dependent signaling of β- and γ-catenins. As expected, sKD
of β-catenin leads to decreased TOPflash activity (Figure 5C). A dKD
of β- and γ-catenins shows a decrease in Wnt signaling, but there is no
additional impact of γ-catenin KD on the TOPflash reporter activity
(Figure 5C ), suggesting that γ-catenin does not contribute to Wnt
signaling and therefore cannot compensate for β-catenin loss in the
Wnt signaling cascade in HCC cells.
Interestingly, there is a significant increase in TOPflash activity
with γ-catenin sKD (Figure 5C ). This was in agreement with the
increase in β-catenin levels in the non–E-cadherin–bound fraction,
after γ-catenin sKD, and further supports that the increased β-catenin
after γ-catenin sKD is nuclear (Figure 5B). To directly address this
biologically, we examined [3H]thymidine incorporation with dKD
and sKD of β- and γ-catenins as a measure of cell proliferation. As
expected, and in agreement with TOPflash reporter activity, we observe
a decrease in thymidine incorporation after sKD of β-catenin or dKD of
both catenins. However, also in concordance with TOPflash results,
there is an increase in proliferation with γ-catenin sKD, albeit at 72 hours
and not 48 hours after KD, which is most likely due to physiological
delay in transactivation of cell cycle–related target genes governing this
event (Figure 5D).
dKD of β- and γ-Catenins In Vitro Decreased
E-Cadherin Levels
Since γ-catenin associated with E-cadherin in the absence of β-catenin,
and β-catenin–E-cadherin association prevents degradation of E-cadherin
bymasking the PEST domain in E-cadherin, we next asked if γ-catenin–
E-cadherin association could have similar function in E-cadherin stabil-
ity. Hep3B cells subjected to sKD and dKD of catenins were assayed for
E-cadherin levels byWB.While comparable levels of E-cadherin protein
were observed in control siRNA-transfected Hep3B cells, and after sKD
Figure 3. sKD of β-catenin protein accurately replicates conditions of β-catenin KO in vivo. (A) siRNA (siβ-catenin) induces efficient KD of
β-catenin (92 kDa) in Hep3B cells and leads to an increase of γ-catenin (83 kDa) protein levels. (B) Whole-cell lysates from siβ-catenin and
siNegative-treated Hep3B cells were immunoprecipitated with anti–E-cadherin or anti–γ-catenin antibodies. WB performed for γ-catenin
(upper panel) and E-cadherin (120 kDa; lower panel) shows differential co-precipitation with sKD of β-catenin. (C) Hep3B and HepG2
cells treated with ASO to β-catenin show a decrease in β-catenin protein and subsequent increase in γ-catenin by WB. Both the WT and
truncated forms of β-catenin in HepG2 cells show decrease with ASO. (D) KD of β-catenin activity using small molecule inhibitor ICG-001
does not change the protein levels of β- or γ-catenin, despite the decrease in β-catenin activity indicated by a decrease in its target cyclin
D1 (37 kDa).
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of β-catenin or γ-catenin, a notable decrease was observed in dKD
(Figure 5E). These data suggest that just like β-catenin, γ-catenin can
bind effectively to E-cadherin and prevent its degradation inHCC cells.
dKD of β- and γ-Catenins In Vitro Increases Rate of
Migration of HCC Cells in Wound Closure Assay
We next queried if γ-catenin up-regulation after β-catenin KD in
HCC cells is conserving cell adhesions comparable to β-catenin.
Hep3B cells after sKD or dKD were used for scratch wound assay
to measure cell migration as described in Materials and Methods
section. We observe that while with an sKD of either β-catenin or
γ-catenin alone leads to no significant change in the percentage of
wound closure after 24 hours, the dKD of both catenins significantly
enhances wound closure at this time when compared to Hep3B cells
treated with a negative control siRNA (Figure 6, A and B). These
data indicate that the dKD of β- and γ-catenins is detrimental to
overall cell adhesion thus increasing cell migration, while sKD of
β-catenin is adequately compensated by γ-catenin and sKD of γ-catenin
has no impact by AJ since E-cadherin–β-catenin association remains
unaltered as shown earlier (Figure 5B).
Figure 4. Mechanism of γ-catenin stabilization after sKD of β-catenin. (A) Real-time PCR for γ-catenin gene (JUP) and GAPDH reference
gene shows insignificant difference in average mRNA expression (±SD) in siβ-catenin versus siNegative Hep3B-treated cells at 48-hour
KD (n = 3). (B) Treatment of Hep3B cells for 3 hours with 10 or 25 nM OA, a known serine/threonine phosphatase inhibitor, results in
increase in γ-catenin (83 kDa) as shown in a representative WB. (C) Treatment of Hep3B cells with various serine/threonine kinase inhibitors
for 3 hours after 45 hours of transfection with control or β-catenin siRNA reveals a decrease in stabilization of γ-catenin after H-89 (PKA
inhibitor). The numbers below the WB represent integrated optical density normalized to GAPDH (loading control) for the respective lane.
(D) Treatment of Hep3B cells with H-89 at 150 nM and 20 μM for 3 hours after 21 or 45 hours of transfection with siβ-catenin or siNegative
reveals a dose- and time-dependent decrease in extent of γ-catenin stabilization. The numbers below the WB represent integrated optical
density normalized to GAPDH (loading control) for the respective lane.
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dKD of β- and γ-Catenins in Hep3B Cells
Negatively Affects Cell-Cell Adhesion
To more directly test the functionality of γ-catenin at cell-cell
adhesions after β-catenin KD, we next employed a CAFCA to com-
pare the overall strength of cell-cell adhesions after sKD and dKD
using Hep3B cells as described in Materials and Methods section.
siRNA-treated Hep3B cells were plated on an untreated monolayer
of Hep3B cells and subjected to a centrifugal force of 375g. At this
force, we observed a significant decrease in cell-cell adhesion as mea-
sured by an increase in the percentage of cells lost, only with the dKD
of β- and γ-catenins, when compared to control or sKD (Figure 6C ).
To further validate cadherin-mediated cell-cell adhesions specifi-
cally (as in [37]), we used a hanging drop assay, where cells are cul-
tured in suspension. After 24 hours in suspension, all the treatments
formed colonies of relatively similar size; however, the dKD colonies
appeared smaller and more asymmetric than others (Figure 6D, upper
panel ). To confirm that we were measuring calcium-dependent or
cadherin-mediated adhesion, the single-cell suspension of Hep3B
Figure 5. sKD and dKD of β- and γ-catenins with siRNA in Hep3B, a human HCC cell line, and impact on Wnt signaling, DNA synthesis,
and E-cadherin. (A) Representative WBs showing a time course of sKD and dKD of β- and γ-catenins using siRNA in Hep3B cells. KD begins
at 24 hours and persists for 72 hours after transfection. (B) Whole-cell lysates from siγ-catenin and siNegative-treated Hep3B cells were
immunoprecipitated with an anti–β-catenin antibody. WB shows no changes in β-catenin’s association with AJ protein E-cadherin. (C) Wnt
reporter (TOPflash) activity is significantly decreased after sKD of β-catenin and dKD; however, there are insignificant differences between
these two groups. A significant increase of TOPflash activity is observed after sKD of γ-catenin at 48 hours (P< .01; ±SD; asterisk indicates
significance compared to siNegative; NS, not significant). (D) Upper panel: Thymidine incorporation (counts per minute) for sKD and dKD
shows a significant but comparable decrease in DNA synthesis with sKD of β-catenin and dKD compared to siNegative. No change in DNA
synthesis with sKD of γ-catenin at 48-hour KDwas observed. Lower panel: Thymidine incorporation decreased comparably and significantly
for sKD of β-catenin and dKD at 72 hours as well. A significant increase in DNA synthesis was observed with sKD of γ-catenin at 72-hour
KD (P < .01; ±SD; asterisk indicates significance compared to siNegative; NS, not significant). (E) Representative WBs from lysates
of Hep3B cells show a modest decrease in E-cadherin after dKD at 48 hours, while comparably higher levels are observed in sKD and
siNegative conditions.
Neoplasia Vol. 15, No. 4, 2013 γ-Catenin Reciprocates β-Catenin at AJ Wickline et al. 429
Figure 6. dKD of β- and γ-catenins affects cell migration and cell-cell adhesion in vitro. (A) Representative images of wound closure at
24 hours after initiation of the wound and 48 hours after transfection with various siRNAs. (B) Scratch wound assay for sKD and dKD
Hep3B cells shows a significant increase in wound closure percentage for dKD of β- and γ-catenins only (P< .01; ±SD; asterisk indicates
significance compared to siNegative). (C) CAFCA with sKD and dKD Hep3B cells shows a significant decrease in heterotypic cell-cell
adhesion with dKD of β- and γ-catenins only (P < .01; ±SD; asterisk indicates significance compared to siNegative) as measured by
increase in percentage of cells that de-adhere from the monolayer after centrifugation at 375g for 10 minutes. (D) Hanging drop assay
shows that at 24 hours after drop formation (72-hour transfection) the colonies formed appear similar in size, though the dKD and sKD of
β-catenin colonies appear to be less symmetric than the sKD γ-catenin and siNegative colonies. After pipetting, the dKD cells dissociate
themost, indicating weaker homotypic cell-cell adhesions. Addition of EGTA, a calcium chelator, to siNegative-treated cells was used as a
control to show that colonies formed were calcium-dependent or cadherin-based cell-cell adhesion.
430 γ-Catenin Reciprocates β-Catenin at AJ Wickline et al. Neoplasia Vol. 15, No. 4, 2013
cells transfected with control siRNA was also cultured in the presence
of EGTA, a calcium chelator, which led to the absence of any colony
formation after 24 hours, indicating that indeed these colonies re-
quired calcium to make new cell-cell adhesions (Figure 6D). When
the colonies of hanging drop cultures were triturated, only the dKD
dissociated readily to single-cell suspension, indicating weaker homo-
typic intercellular adhesions (Figure 6D).
Together, the data support maintenance of AJ by γ-catenin upon
β-catenin loss and that concomitant decrease of β- and γ-catenins will
be detrimental to intercellular adhesion and effectiveness of AJ.
Discussion
Anti–β-catenin therapies for treatment of various cancers including
HCC are on the horizon [13,56]. In the current study, we addressed
the consequences of altering β-catenin expression on the cadherin-
based cell-cell adhesions and Wnt signaling due to ensuing compen-
sations to determine if anti–β-catenin therapies may have unintended
negative consequences on the progression of HCC. The observation
that γ-catenin is upregulated after β-catenin loss both in vitro and
in vivo and that γ-catenin can function at the AJ and as a part of Wnt
signaling while being a natural component of desmosomes required
extensive analysis to address both normal and acquired functions of
γ-catenin in these circumstances.
It was important to initially address the influence of γ-catenin
changes with β-catenin loss on the desmosomes, especially since the
trafficking of γ-catenin to the AJ is controlled posttranscriptionally
[31,41,46]. Additionally, disruptions in desmosomes have been shown
to play a role in cancer progression [20,57,58], and thus compensation
by γ-catenin at AJ may come at the expense of desmosomal integrity,
which may have unintended negative side effects upon β-catenin thera-
peutic targeting inHCC.Wehave previously shown using a hepatocyte-
specific β-catenin KO mouse that γ-catenin is increased and
compensating for β-catenin loss at AJ by complexing with E-cadherin
[31]. We now show that such compensation does not have any func-
tional consequences on desmosomal structure in the liver. This was
confirmed in multiple ways, including the observation that the γ-catenin/
E-cadherin/Pkp3 cytoplasmic complex, which has been shown to be
important for desmosomal assembly [48], was unchanged in KO mice.
We also show that the structure of desmosomes was not affected in vivo.
We did, however, see an increase in Pkp3 but are unable to explain the
significance of this increase at this time. We speculate that Pkp3 in-
crease after β-catenin loss may be more directly related to the changes
in Wnt signaling than changes in AJ since we did not see changes in
Pkp3 localization through fractionation or co-precipitation studies and
still remains under scrutiny in our laboratory.
To fully investigate the impact of β-catenin loss on cell-cell adhe-
sions, we employed an in vitromodel of catenin KD. Having an in vitro
model gives us the ability to modulate the two catenins singly or in
combination and determine the impact through the simple readouts.
Hep3B cells lent themselves well for such a model, although the role
and regulation of γ-catenin upon β-catenin KD was also evident in
other cell lines such as HepG2 cells and by other modalities of KD such
as ASOs.
Adhesion of Hep3B cells to another monolayer of Hep3B cells
through CAFCA was modestly and significantly decreased upon
dKD of β- and γ-catenins. We ascribe the modest changes in the
CAFCA to junctional crosstalk and compensation, which we have
previously observed in the in vivo KO of β-catenin [31,34] and have
also been seen in the in vivo models of γ-catenin KD [55,59]. There
are known nodes of crosstalk between AJ and desmosomes [60], AJ
and tight junctions [61], along with AJ and gap junctions [62]. We
propose that such redundancies enable maintenance of cell-cell adhe-
sions in epithelial cells and hence be permissive to therapies that may
affect a junctional protein like β-catenin.
To tease out the exact roles of β- and γ-catenins on desmosomes
and AJ, we used more specific assays for isolating cadherin-mediated
adhesions. The hanging drop assay confirmed that cadherin-mediated
adhesion is greatly decreased with the dKD of β- and γ-catenins but
not with either sKD. This indicates that at least one of these catenins
is necessary for the proper maintenance of cadherin-mediated junc-
tions, corroborating the data put forth previously [37]. These data
may also be influenced by the fact that we see an overall decrease in
E-cadherin levels in our dKD Hep3B cells, which would reduce the
pool of E-cadherin available for dimerization and assembly of AJ and
would most likely reduce the overall number of AJ as well. The de-
crease in E-cadherin levels may be a result of the lack of catenins
available to traffic E-cadherin to the membrane. β-Catenin interacts
with E-cadherin to mask the PEST domain of E-cadherin, preventing
its recognition by the proteasome [63]. Thus, on the basis of the
similarities of β- and γ-catenin interactions with E-cadherin [15], we
assume that γ-catenin allows for E-cadherin stabilization by masking
its PEST domain, at least in vitro, and after acute β-catenin KD. Indeed,
various studies have postulated that the interactions of β-catenin and
γ-catenin with E-cadherin are indistinguishable. Choi and others
showed that the crystal structures of β-catenin and γ-catenin with
E-cadherin were nearly identical, although the dissociation constant
of β-catenin binding to E-cadherin was nearly twice compared to
γ-catenin (41 and 85 nM, respectively) [15]. This may suggest some
minor differences in the interactions between the two catenins and
E-cadherin. However, our data do indicate that at least one of the
catenins is necessary for the maintenance of cadherin-mediated junc-
tions and for steady-state E-cadherin expression.
Our study also demonstrates that decreasing β-catenin levels blocks
canonical Wnt signaling, which is the major contributor toward HCC
cell proliferation and survival. γ-Catenin increase with β-catenin KD is
unable to compensate for β-catenin signaling, as shown by TOPflash
assay. Indeed, in our previous studies, we failed to detect any increase
in nuclear γ-catenin in β-catenin KO livers even at times of ongoing
proliferation [31]. Similarly, despite γ-catenin increase in β-catenin
KO livers, several liver-specific targets of β-catenin such as glutamine
synthetase and cytochrome P450s 2E1 and 1A2 continued to be signif-
icantly downregulated in KO [14].
γ-Catenin increase secondary to β-catenin KD does not worsen
HCC cell phenotype by promoting tumor cell proliferation, migration,
or Wnt activation. Others have published studies indicating that an
increase in γ-catenin leads to enhancement of metastasis through geno-
mic instability and migration [64]. However, we accredit the lack
of detrimental phenotypes seen with γ-catenin increase with sKD of
β-catenin to a strictly compensatory function of γ-catenin in lieu of
β-catenin at the AJ. Thus, γ-catenin appears to have a protective effect
when β-catenin levels are decreased, acting as a tumor suppressor. How-
ever, on its own, γ-catenin appears to have rather mixed effects. While,
on the one hand, sKD of γ-catenin did not negatively impact cell-cell
adhesions or migration, we did observe an increase in proliferation pre-
ceded by an increase in β-catenin signaling. Therefore, in our studies we
observed that γ-catenin does not explicitly act as an oncogene or tumor
suppressor but that its role in HCC cells may be closely linked to that of
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β-catenin, although additional studies like generation of hepatocyte-
specific γ-catenin KO would be necessary. Our data suggest that only
combined inhibition of β-catenin and γ-catenin leads to more migra-
tion of cells and perhaps may induce local invasion and metastasis,
which is a concept also shown previously in a clinical study, where
it was not the overall levels of catenins that determined the progno-
sis of HCC, but instead it correlated better with combined expres-
sion of catenins and E-cadherin. Specifically, the authors observed
poor prognosis and survival rate in HCC patients exhibiting decrease
in both γ-catenin and E-cadherin and not a decrease in γ-catenin
alone [21].
We next addressed the molecular basis of γ-catenin increase fol-
lowing β-catenin loss. In our previous work, we identified enhanced
serine/threonine and not tyrosine phosphorylation of γ-catenin [31].
This mechanism was also verified in vitro when OA, a known serine/
threonine phosphatase inhibitor, induced γ-catenin levels in Hep3B cells
[23,25,50,51]. γ-Catenin is indeed known to undergo serine/threonine
phosphorylation [41]. Since cytoplasmic but not insoluble membrane-
associated pool of γ-catenin showed serine and threonine phosphoryla-
tion, it suggests that phosphorylation may prevent γ-catenin degradation
during cytoplasmic trafficking [41]. In our studies, on the basis of the
overlap of activities of various kinase inhibitors used and observed
dose-dependent response, it appears that PKA is the candidate serine/
threonine kinase responsible for phosphorylating γ-catenin to induce its
stabilization in the absence of β-catenin. Although additional mutagene-
sis studies will be essential, in silico analysis identified 23 putative PKA
substrate motifs located throughout γ-catenin protein. Future studies will
address PKA-dependent phosphorylation for specific residues in γ-catenin
that are critical for its stabilization especially after β-catenin KD.
Preclinical β-catenin inhibitors being investigated can be broadly
categorized into two classes: 1) those that block the nuclear β-catenin
without impacting the total levels of β-catenin (such as ICG-001 and
pegylated interferon-α2a) [8,11] and 2) those that suppress β-catenin
gene and/or protein expression such as ASO or other indirectly acting
agents [10,65–68]. Results from ASO, siRNA, and ICG-001 studies
indicate that it is the absolute levels of β-catenin and not a decrease
in β-catenin’s transactivational activity that provides an impetus for
γ-catenin stabilization and that the compensation by γ-catenin is
at the AJ only and the functions of β-catenin as a part of the Wnt
pathway remain unfulfilled by γ-catenin. This suggests that there
may exist a catenin-sensing mechanism in a cell, which monitors
the levels of catenins especially at junctions and allows for compen-
sation for these proteins by others through relatively prompt post-
translational modifications. We propose that PKA may be such a
sensor, which stabilizes γ-catenin and is also known to phosphorylate
β-catenin at serine 552 and 675 to induce its activation [69]. Whether
PKA normally phosphorylates membrane-bound β-catenin is not
known, although the two effector serine/threonine sites are in close
proximity to tyrosine 654 and 670, which are the sites phosphory-
lated by receptor tyrosine kinases known to deregulate E-cadherin–
β-catenin complex at AJ [70,71]. We therefore propose that when
β-catenin levels diminish, PKA is unable to activate β-catenin, which
now switches substrates to phosphorylate γ-catenin instead and this
induces γ-catenin stabilization to at least fulfill the role of β-catenin
at the AJ. While this hypothesis needs further experimental proof, it
does demonstrates the feasibility of β-catenin–decreasing agents as
therapies for HCC, provided γ-catenin stabilization factors such as
PKA are spared for adequate compensation at junctions to prevent
untoward effects on tumor cell migration, invasion, and metastasis.
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Table W1. List of Antibodies.
Protein Antibody Species kDa WB Dilution IF Dilution IP Dilution Company Product Number
β-Actin Mouse 42 1:2500 X X Millipore MAB1501
β-Catenin Mouse 92 1:1000 X X BD 610154
β-Catenin Rabbit 92 X 1:150 X Santa Cruz Biotechnology sc-7199
β-Catenin Goat X X X 1:50 Santa Cruz Biotechnology sc-1496 AC
Cyclin D1 Mouse 37 1:200 X X Santa Cruz Biotechnology sc-20044
Dsc2 Goat 110 1:200 X X Santa Cruz Biotechnology sc-34311
Dsg1 Rabbit 150/160 1:200 X X Santa Cruz Biotechnology sc-20114
Dsg2 Rabbit 59–150 1:200 X X Santa Cruz Biotechnology sc-20115
Dsg3 Goat 108/130/100/80/75/55 1:200 X X Santa Cruz Biotechnology sc-14867
Dsg4 Goat 99/115 1:200 X X Santa Cruz Biotechnology sc-28069
DPI/II Rabbit 210/250 1:200 X X Santa Cruz Biotechnology sc-33555
E-cadherin Rabbit 120 X X 1:50 Santa Cruz Biotechnology sc-7870
E-cadherin Mouse 120 1:1000 X X BD 610182
γ-Catenin Rabbit 80–87 1:1000 1:50 1:100 Cell Signaling Technology 2309
γ-Catenin Goat 80–87 1:200 1:50 X Santa Cruz Biotechnology sc-30997
γ-Catenin Goat 80–87 1:200 1:50 X Santa Cruz Biotechnology sc-30996
GAPDH Rabbit 37 1:1000 X X Santa Cruz Biotechnology sc-25778
Pkp2 Goat 100 1:200 X X Santa Cruz Biotechnology sc-18977
Pkp3 Mouse 87 1:200 X X Santa Cruz Biotechnology sc-166655
Pkp3 Rabbit 87 1:500 X X Abcam ab109441
GAPDH indicates glyceraldehyde-3-phosphate dehydrogenase.
Table W2. Real-Time PCR Primer Sequences.
Gene Species Direction Sequence Reference
JUP Human Forward 5′-AAG GTG CTA TCC GTG TGT CC-3′ [71]
JUP Human Reverse 5′-GAC GTT GAC GTC ATC CAC AC-3′ [71]
GAPDH Human Forward 5′-TGC ACC ACC AAC TGC TTA GC-3′ [72]
GAPDH Human Reverse 5′-GGC ATG GAC TGT GGT CAT GAG-3′ [72]
